Lv63
2046 积分 2021-09-17 加入
Chinese Humanities and Social Sciences Scholars' Language Choices in International Scholarly Publishing: A Ten-Year Survey
4小时前
已关闭
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
10天前
已完结
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
11天前
已完结
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
11天前
已完结
Successful Use of Adjunctive Orbital Atherectomy for Extensively Calcified Carotid Artery Lesions Using Flow Reversal Neuroprotection Technique
11天前
已关闭
Metaverse and Telementoring: From Surgery to Workshop
1个月前
已完结
Early screening and management of lung cancer: a weapon to solve the problem of lung cancer in China
1个月前
已完结
2025 FDA approvals
1个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
1个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
1个月前
已完结
皖公网安备34019202002308
